US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist
  • 26.850
  • +3.240+13.72%
Close Aug 9 16:00 ET
  • 26.850
  • 0.0000.00%
Post 20:01 ET
1.02BMarket Cap-6020P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tarsus Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 8, 2024

Revenue(YoY)

40.81M

0.00%
EPS(YoY)

-0.88

+24.79%
Analyst Rating

Strong Buy

Aug 10, 2024

Tarsus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 52.882M--
--2024/Q3-- / 44.094M--
Aug 8, 20242024/Q240.813M / 32.048M--
May 8, 20242024/Q127.614M / 17.898M--
Feb 27, 20242023/Q413.076M / 5.924M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 52.882M--
--2024/Q3-- / 44.094M--
Aug 8, 20242024/Q240.813M / 32.048M--
May 8, 20242024/Q127.614M / 17.898M--
Feb 27, 20242023/Q413.076M / 5.924M--

Unlock Free Earnings Estimates

Tarsus Pharmaceuticals Earnings Reports

  • Tarsus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:21 ET

  • Tarsus Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 8 17:19 ET

  • Tarsus Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 27 16:10 ET

  • Tarsus Pharmaceuticals: Q3 2023 Earnings Report

    Nov 9, 2023 16:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 10, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-4.29%